Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T05:00:40.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T04:45:51.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T05:26:47.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    403 Forbidden error page is now shown, replacing the expected study record content. The page includes the standard header, navigation, and footer, indicating access is blocked rather than a new or edited study entry.
    Difference
    18%
    Check dated 2026-09-20T03:08:54.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The study page shows an updated revision label from v3.6.5 to v3.6.6, indicating a small documentation update.
    Difference
    0.1%
    Check dated 2026-08-29T23:51:27.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page revision line now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a newly published revision in the site’s version history.
    Difference
    0.1%
    Check dated 2026-08-08T22:31:29.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.